Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 99 | ECE2024

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

Card image cap
We are pleased to announce that ECE 2024 will be held in Stockholm, Sweden from 11-14 May 2024. We will, once again, be offering the hybrid format next year so you can join us in person in Sweden or remotely with ECE@Home.

Rapid Communications

Rapid Communications 2: Calcium and Bone | Part I

ea0099rc2.1 | Rapid Communications 2: Calcium and Bone | Part I | ECE2024

Genetics of congenital hypoparathyroidism and pseudohypoparathyroidism: results of a multigenic screening in an Italian cohort of affected patients

Marini Francesca , Giusti Francesca , Cetani Filomena , Mantovani Giovanna , Garagnani Paolo , Brandi Maria Luisa

Introduction: Hypoparathyroidism (HPT), pseudohypoparathyroidism (PHP), and end-organ parathyroid hormone (PTH)-resistance are rare metabolic disorders characterized by low serum calcium and increased serum phosphorus due to a PTH-deficient or resistant state. Various genes/loci have been identified as responsible for the development of congenital/familial forms of HPT, PHP and related diseases.Patients and Methods: A total of 39 patients with a clinical...

ea0099rc2.2 | Rapid Communications 2: Calcium and Bone | Part I | ECE2024

Irisin levels are correlated with age and behavioural performance in Post-surgical HypoPT condition

Saponaro Federica , Chiellini Grazia , Polini Beatrice , Ricardi Caterina , Pignataro Patrizia , Zerlotin Roberta , Oranger Angela , Colucci Silvia , Di Carlo Manuela , Colaianni Graziana , Saba Alessandro , Grano Maria

Introduction: Hypoparathyroidism (HypoPT) is a rare endocrine disease and Post-surgical HypoPT (PS-HypoPT) is the most common cause, caused by accidental parathyroid injury. From a neuropsychological standpoint, patients with PS-HypoPT present cognitive and neuropsychological symptoms. Irisin is a myokine secreted by contracting muscle, which mediates beneficial effects on several targets, including brain. The aim of this study was to evaluate irisin in the context of PS-HypoP...

ea0099rc2.3 | Rapid Communications 2: Calcium and Bone | Part I | ECE2024

Metformin prevents glucocorticoid-induced bone resorption in healthy subjects

Pfammatter Stephanie , Lisa Zanetti , Thierry Susanne , Meier Christian , Seelig Eleonora

Background: Glucocorticoids are crucial for treating various medical conditions due to their beneficial immunosuppressive effects. However, glucocorticoids also carry a high risk for osteoporosis. Notably, within just a few months of glucocorticoid therapy, bone density can be significantly reduced, and up to 5% of patients undergoing such treatment may experience fractures. There is promising evidence from preclinical studies and observations in patients with type 2 diabetes ...

ea0099rc2.4 | Rapid Communications 2: Calcium and Bone | Part I | ECE2024

Primary hyperparathyroidism in children and adolescents: Clinical features and treatment outcomes from an Italian multicenter study

Cetani Filomena , Della Valentina Simone , Scillitani Alfredo , Dal Lago Anna , Pierotti Laura , Sardella Chiara , Madeo Bruno , Cairoli Elisa , Eller Vainicher Cristina , Procopio Massimo , Barale Marco , Palmieri Serena , Gianotti Laura , Castellano Elena , Lania Andrea , Pitea Marco , Lanzi Roberto , Maggiore Riccardo , Cipriani Cristiana , Pepe Jessica , Corbetta Sabrina

Primary hyperparathyroidism (PHPT) is rare in the pediatric population, with an estimated incidence of 0.5–5 cases per 100,000 person-years in children. Data regarding the clinical phenotype, the surgical outcomes are scarce. The objective of our study was to retrospectively analyze the phenotype of apparently sporadic PHPT in patients ≤21 years in major endocrinology reference centers in Italy. None of the patients had known familial syndromes. A total of 41 patien...

ea0099rc2.5 | Rapid Communications 2: Calcium and Bone | Part I | ECE2024

Genetic testing for syndromic conditions in patients referred with primary hyperparathyroidism: a retrospective observational analysis

Than Yu Kyi Pyar , Gregory Andrew , Abdulkareem Mustafa , Jose Biju , Varadhan Lakshminarayanan

Background and Aim: Primary hyperparathyroidism (PHPT) is a common endocrine disorder. A small proportion of these patients may have syndromic conditions such as multiple endocrine neoplasia (MEN) or familial hypocalciuric hypercalcemia (FHH). The UK national guidelines recommend genetic testing for familial hyperparathyroidism in individuals under 50 or any age with specific criteria such as family history, multi glandular disease, hyperplasia, or parathyroid carcinoma. Genet...

ea0099rc2.6 | Rapid Communications 2: Calcium and Bone | Part I | ECE2024

Role of FGF23 in patients with transfusion-dependent β-thalassemia and hypercalciuria

Gobbo Alberto , Chamekh Fatima , Cattaneo Camilla Alice , Verrienti Martina , Pizzicotti Stefano , Longo Filomena , Chiara Zatelli Maria , Ambrosio Maria Rosaria

Introduction: Patients with transfusion-dependent β-thalassemia (TDT) frequently exhibit elevated urinary calcium excretion, contributing to kidney stone formation and osteoporosis. The underlying mechanism of hypercalciuria in β-thalassemia remains elusive, with FGF23 playing a potential role. FGF23, a bone-derived hormone, primarily acts on the kidneys by inhibiting phosphate reabsorption in the proximal tubules while enhancing calcium uptake in the distal tubules....